2012 - My American Heart - American Heart Association

More documents

Recommendations

Info

Pooja Khatri P Khatri: Research Grant; Significant; NIH. Other Research Support; Significant, Penumbra – THERAPY Trial Neurology PI. Other Research Support; Modest; rtPA Survey Study, Genentech. Other; Modest; Domestic travel (unpaid consultant). Christopher J. Moran C Moran: Consultant/Advisory Board; Modest; Codman, Stryker. Consultant/Advisory Board; Significant; EV3. Lewis Morgenstern L Morgenstern: Other Research Support; Modest; St. Jude Medical Corporation. Bruce Ovbiagele B Ovbiagele: Research Grant; Modest; NIH/NINDS U54 NS057405. Aman Patel A Patel: Honoraria; Significant; Codman Neurovascular, Penumbra Neurovascular. Consultant/Advisory Board; Significant; Codman Neurovascular, Penumbra Neurovascular. Peter Rasmussen P Rasmussen: Honoraria; Modest; ev3/Covidien, Penumbra Medical, Columbia University. Consultant/Advisory Board; Modest; Codman Neurovascular, Possis Medical/Medrad. Other; Modest; Informa Health - Author/Royalty. Ownership Interest; Significant; Blockade Medical. Joel Stein J Stein: Research Grant; Modest; Tibion, Inc. Other Research Support; Modest; Tyromotion, Inc – Loan of equipment. Consultant/Advisory Board; Modest; <strong>My</strong>omo, Inc. – Unpaid member of scientific Advisory Board. Jiguang Wang J Wang: Research Grant; Modest; A&D. Consultant/Advisory Board; Modest; Pfizer, A&D. Honoraria; Modest; Pfizer. Sam (Osama) Zaidat O Zaidat: Consultant/Advisory Board; Modest; Stryker, Codman Neurovascular, EV3. This table represents the relationships of program committee members which may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire which all members of the program committee are required to complete and submit. A relationship is considered to be “Significant” if (a) the person receives $10,000 or more during any 12 month period, or 5% or more of the person's gross income; or (b) the person owns 5% or more of the voting stock or share of the entity, or owns $10,000 or more of the fair market value of the entity. A relationship is considered to be “Modest” if it is less than “Significant” under the preceding definition. Committee members who had nothing to disclose are not listed below 7
STROKE HAS DROPPED FROM THE NO. 3 TO NO. 4 CAUSE OF DEATH IN AMERICA! CONGRATULATIONS! DUE IN PART TO YOUR EFFORTS, STROKE HAS FALLEN TO THE FOURTH-LEADING CAUSE OF DEATH IN AMERICA. THIS IS THE FIRST SUCH DECLINE IN 50 YEARS. DESPITE THIS GOOD NEWS, THE AHA/ASA HAS MORE WORK AHEAD BECAUSE MORE PEOPLE THAN EVER ARE LIVING WITH STROKE. We must continue to make scientific advancements to reduce deaths, improve quality of care and educate people about this deadly disease. Thank you for all you have done and for what you will do in the future. To help continue your efforts, here are some stroke resources for you and your patients: ��heart.org/hypertensiontoolkit ��powertoendstroke.org/ healthcare.html ��Stroke Connection e-Zine strokeassociation.org/strokeconnection ��
Page 1 and 2: International Stroke Conference Fin
Page 3 and 4: TUES.• JAN. 31 WED. • FEB. 1 TH
Page 5 and 6: 2 Abstract Grading Consultants (con
Page 7: 4 Abstract Grading Consultants (con
Page 12 and 13: The American Stroke Association is
Page 14 and 15: International Stroke Conference Feb
Page 16 and 17: onsite for attendance verification
Page 18 and 19: Medical Emergencies The First Aid S
Page 20 and 21: You must wear your name badge at al
Page 22 and 23: learn.heart.org This Web site is wh
Page 24 and 25: Thursday, Feb 2, 2012, 12:45 - 2:00
Page 26 and 27: Posters Professor-Led Poster Tours
Page 28 and 29: The American Heart/ American Stroke
Page 30 and 31: State-of-the-Art Stroke Nursing Sym
Page 32 and 33: To successfully complete this activ
Page 34 and 35: 3:15 pm - 3:45 pm Short Break 3:45
Page 36 and 37: Start Planning Now for the State-of
Page 38 and 39: PRE-CONFERENCE
Page 40 and 41: ISC Pre-Conference Symposium 2012 I
Page 42 and 43: IN ACUTE ISCHEMIC STROKE, TIME IS B
Page 44 and 45: For changes to the program made sin
Page 46 and 47: 7:42 Outcomes Of Carotid Endarterct
Page 48 and 49: 8:18 Linxin Li, Univ of Oxford, Oxf
Page 50 and 51: State Univ, East Lansing, MI; Eric
Page 52 and 53: 10:39 Discussion Session II: Concur
Page 54: 9:27 Influence of Antithrombotics o
Page 57 and 58: 48 E Sander Connolly, MD, New York,
Page 59 and 60: 50 Moderators: Katie D Vo, MD, Sain
Page 61 and 62:
52 3:00 F Bladin, Box Hill Hosp, Me
Page 63 and 64:
54 4:57 Can Blood Biomarkers Improv
Page 65 and 66:
56 5:24 Discussion Session V: Concu
Page 67 and 68:
58 5:00 Socioeconomic Status Is Ass
Page 69 and 70:
Extend your quality care after disc
Page 71 and 72:
THURSDAY, FEB. 2 American Heart Ass
Page 73 and 74:
62 7:30 What More Evidence Do You W
Page 75 and 76:
64 Univ Boonshoft Sch of Med, Dayto
Page 77 and 78:
66 7:42 Mitochondrial Depolarizatio
Page 79 and 80:
68 Session VII: Concurrent E Basic
Page 81 and 82:
70 Bejoy Thomas, Dept of Imaging Sc
Page 83 and 84:
72 11:26 Introduction of the Highes
Page 85 and 86:
74 2:00 Introduction Eric E Smith,
Page 87 and 88:
76 2:36 High Intake of Caffeine use
Page 89 and 90:
78 Session IX: Concurrent G Late-Br
Page 91 and 92:
80 Session X: Concurrent Symposia C
Page 93 and 94:
82 4:41 Discussant 4:46 Q & A 4:54
Page 96 and 97:
International Stroke Conference ISC
Page 98 and 99:
For changes to the program made sin
Page 100 and 101:
8:1 2 Impact Of Obesity And Metabol
Page 102 and 103:
8:12 Pharmacological Stroke Prophyl
Page 104 and 105:
9:52 Hemodynamics and Anatomic Eval
Page 106 and 107:
11:04 Discussion Session XII: Concu
Page 108 and 109:
11:30 am - 1:00 pm Session XIII: Pl
Page 110 and 111:
PROFESSIONAL MEMBERSHIP my.american
Page 112 and 113:
POSTER HALL, HALL B MODERATED POSTE
Page 114 and 115:
PROFESSOR-LED POSTER TOURS BY CATEG
Page 116 and 117:
Acute Neuroimaging MP13 - MP18 Mode
Page 118 and 119:
Cerebrovascular Occlusive Disease M
Page 120 and 121:
Poster Board Number MP36 / Presenta
Page 122 and 123:
Neurology, Univ of Alberta, Edmonto
Page 124 and 125:
Page 126 and 127:
Preventive Strategies MP79 - MP84 M
Page 128 and 129:
POSTER SESSION I WEDNESDAY, FEBRUAR
Page 130 and 131:
Poster Board Number P15 / Presentat
Page 132 and 133:
WEDNESDAY Takeshi Iwanaga, Okayama
Page 134 and 135:
of Neurology, Royal Melbourne Hosp,
Page 136 and 137:
WEDNESDAY Cheolkyu Jung, Dept of Ra
Page 138 and 139:
Page 140 and 141:
WEDNESDAY Poster Board Number P92 /
Page 142 and 143:
WEDNESDAY Poster Board Number P104
Page 144 and 145:
Page 146 and 147:
Giuseppe Giordano, Gioele Simonte,
Page 148 and 149:
Page 150 and 151:
WEDNESDAY Physicians and Surgeons o
Page 152 and 153:
Jacksonville, FL; Andrew M Southerl
Page 154 and 155:
Karlheinz Bürgelin, Julius von Sü
Page 156 and 157:
Poster Board Number P206 / Presenta
Page 158 and 159:
Page 160 and 161:
WEDNESDAY Program, Dept of Clinical
Page 162 and 163:
WEDNESDAY Kyoko Motomura, Kyoko Mot
Page 164 and 165:
Page 166 and 167:
Page 168 and 169:
WEDNESDAY Intravenous Thrombolysis
Page 170 and 171:
Page 172 and 173:
Page 174 and 175:
Page 176 and 177:
Acute Neuroimaging Moderated Poster
Page 178 and 179:
Page 180 and 181:
Cincinnati, Cincinnati, OH; Sylvia
Page 182 and 183:
Page 184 and 185:
Page 186 and 187:
Jonas H Ellenberg, Ebbing Lautenbac
Page 188 and 189:
Page 190 and 191:
Poster Board Number P6 / Presentati
Page 192 and 193:
Acute Neuroimaging Posters II P19 -
Page 194 and 195:
THURSDAY Poster Board Number P33 /
Page 196 and 197:
Page 198 and 199:
Cerebrovascular Occlusive Disease P
Page 200 and 201:
Page 202 and 203:
THURSDAY Reverté Villarroya, Laura
Page 204 and 205:
Page 206 and 207:
THURSDAY Alan Bryer, Dept of Neur,
Page 208 and 209:
THURSDAY Molecular Biology, Sch of
Page 210 and 211:
Page 212 and 213:
THURSDAY Mohamed Faouzi, Inst of so
Page 214 and 215:
Page 216 and 217:
Page 218 and 219:
Page 220 and 221:
Page 222 and 223:
Page 224 and 225:
Page 226 and 227:
THURSDAY ON, Canada; on behalf of t
Page 228 and 229:
Jayram-Trouth, Howard Univ, Washing
Page 230 and 231:
HOSPITAL, Columbus, OH; Mark Mackay
Page 232 and 233:
Page 234 and 235:
Page 236 and 237:
LATE-BREAKING SCIENCE ABSTRACTS POS
Page 238 and 239:
WEDNESDAY Poster Board Number LB P1
Page 240 and 241:
ONGOING CLINICAL TRIALS ABSTRACTS P
Page 242 and 243:
Poster Board Number CT P12 / Presen
Page 244 and 245:
THURSDAY Poster Board Number CT P26
Page 246 and 247:
THURSDAY Poster Board Number CT P36
Page 248 and 249:
Connecting the World to Stroke Scie
Page 250 and 251:
FACULTY The list of faculty include
Page 252 and 253:
Anne Dorrance, BS, PhD, FAHA, Michi
Page 254 and 255:
Dawn Kleindorfer, MD, FAHA, Univers
Page 256 and 257:
Ralph L Sacco, MS, MD, FAAN, FAHA,
Page 258 and 259:
ABSTRACT AUTHOR INDEX The following
Page 260 and 261:
Armstead, William 2579 Armstrong, G
Page 262 and 263:
Boden-Albala, Bernadette 2267, 3594
Page 264 and 265:
Channapragada, Theja 3980, 4013, 40
Page 266 and 267:
Cutting, Shawna 3135, 3145 Cysyk, B
Page 268 and 269:
Ehntholt, Amy 31 Ehtisham, Asad 368
Page 270 and 271:
Fu, Jianhui 2743 Fucetola, Robert 2
Page 272 and 273:
Gubitz, Gord 100, 3046 Guentner, Ja
Page 274 and 275:
Hong, Jennifer 3426 Hong, Keun-Sik
Page 276 and 277:
John, Sayona 3879 Johnson, Brenda N
Page 278 and 279:
Kim, Hyunggun 3499 Kim, Helen 3666
Page 280 and 281:
Lansberg, Maarten G 50, 52, 53, 73,
Page 282 and 283:
Longbottom, Mary E 6, 3686, CT P5 L
Page 284 and 285:
McGuire, Michael 2188 McGwin, Geral
Page 286 and 287:
Muir, Keith W 3417, 97 Mulawka, Cat
Page 288 and 289:
Ordin, Diana 2275 Origasa, Hideki C
Page 290 and 291:
Puig, Josep 3785, 3846 Pulley, LeaV
Page 292 and 293:
Ryoo, Na-Young 3490 Ryoo, Sookyung
Page 294 and 295:
Shen, Loren CT P22, LB P5 Shen, Lin
Page 296 and 297:
Straka, Matus 50, 52, 53, 73, 92, 9
Page 298 and 299:
Tranor, Tim 3661 Treister, Andrew 2
Page 300 and 301:
Watson, Nora LB P15 Watson, Sam 306
Page 302 and 303:
Yuan, Bin 3713 Yuan, Chun 2771, 356
Page 304 and 305:
Notes 287
Page 306 and 307:
CEDARS-SINAI. LEADING THE QUEST IN
show all

2012 - My American Heart - American Heart Association

Create successful ePaper yourself

Delete template?

Save as template?